2-27607909-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032434.4(ZNF512):c.1001G>A(p.Ser334Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000478 in 1,614,062 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032434.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF512 | NM_032434.4 | c.1001G>A | p.Ser334Asn | missense_variant | 10/14 | ENST00000355467.6 | NP_115810.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF512 | ENST00000355467.6 | c.1001G>A | p.Ser334Asn | missense_variant | 10/14 | 2 | NM_032434.4 | ENSP00000347648 | P3 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000263 AC: 66AN: 251410Hom.: 0 AF XY: 0.000265 AC XY: 36AN XY: 135878
GnomAD4 exome AF: 0.000496 AC: 725AN: 1461876Hom.: 0 Cov.: 30 AF XY: 0.000458 AC XY: 333AN XY: 727238
GnomAD4 genome AF: 0.000309 AC: 47AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 16, 2021 | The c.1001G>A (p.S334N) alteration is located in exon 10 (coding exon 10) of the ZNF512 gene. This alteration results from a G to A substitution at nucleotide position 1001, causing the serine (S) at amino acid position 334 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at